The Therapeutic Effects of Nicotine in Aβ25-35-induced Alzheimer's Disease Models

任汝静,王刚,潘静,朱亮,张施,孙小康,陈红专,陈生弟

DOI: https://doi.org/10.3321/j.issn:1001-1978.2009.01.015

2009-01-01

Abstract:Aim To investigate the effects of nAChR agonist-nicontine in a mice model of Alzheimer's disease(AD) rendered by Aβ25-35.Methods Mice were administered nicotine(0.2,2 mg·kg-1 ip,bid) for 7 d and control mice received daily ip injections of saline after the intracerebroventricular injection of aggregated Aβ25-35.After the last treatment,passive avoidance and performance in the Morris water maze(MWM) were assessed.The activities of cortical and hippocampal ChAT,AChE,MDA and GSH were detected after the final behavioral test.Results Nicotine(0.2,2 mg·kg-1 ip,bid) significantly ameliorated the learning and memory impairment induced by Aβ25-35.Nicotine(0.2,2 mg·kg-1) decreased the latencies and swim distances of mice to reach a hidden platform and improved the corresponding changes in search strategies occurred in the Morris water maze.Biochemical analysis showed that Nicotine(0.2,2 mg·kg-1) prevented the decline of cortical and hippocampal ChAT and GSH activities induced by Aβ25-35,and showed inhibition of the activity of MDA,although Aβ25-35 showed no effect on the cortical and hippocampal AChE activity compared with the Aβ25-35-induced mice groups.Conclusion Nicotine can reverse Aβ25-35-induced memory retrieval deficits in mice,and this effect was mediated by enhanced activity of ChAT and the inhibition of oxidative stress.